Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
about
Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutationIncidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaCarcinogens induce loss of the primary cilium in human renal proximal tubular epithelial cells independently of effects on the cell cycleSurvey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesionsEpigenetic gene silencing in cancer.Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.Chromatin modification and diseaseTwo hits revisited againTwo single nucleotide polymorphisms in the von Hippel-Lindau tumor suppressor gene in Taiwanese with renal cell carcinoma.An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects.Functional significance of erythropoietin in renal cell carcinoma.Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.Ocular clusterin expression in von Hippel-Lindau diseaseAnalysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinomaCpG island methylation in familial colorectal cancer patients not fulfilling the Amsterdam criteria.Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesisEpimutations, inheritance and causes of aberrant DNA methylation in cancer.Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeuticsTargeted therapy in renal cancer.Successful treatment of erythropoietin-producing advanced renal cell carcinoma after targeted therapy using sunitinib: Case report and review of the literature.Mutations in the von hippel-lindau tumour suppressor gene in central nervous system hemangioblastomasGenetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter.Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis.Medical genetics: advances in brief: Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumours.Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system.Von Hippel-Lindau disease.Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.
P2860
Q24613597-BA5B2330-6633-458A-8A2C-95E02BBC1720Q29615026-9BCA5E3F-BCC6-45F2-9C78-00A2C9CC325FQ30541981-A3A6EA5A-03B5-42CF-8135-8A866CD7B7D1Q30692065-59CB2CBF-EFD6-4DEE-99EE-FFC87A3439B2Q33843160-203C2020-D439-457A-8E1C-1F01D8E5893FQ33918504-6DD248A6-6BAD-47CD-8ED4-1408EAC52C16Q34098840-62E4DFC9-B9B3-44A9-B536-E9A9FFEB8BF6Q34131230-F38002D1-4A62-43F4-818C-6F0A1558F933Q34208511-EBB5C12A-35BA-4823-BB7A-5E5156AF9A74Q34387297-C9A4F885-D7A4-4A5D-AB7F-75AAA3885F0AQ34543726-96199A62-F951-47C9-881C-7355DE6A31D3Q35462032-4116608F-6241-43E8-84EE-2E774817FC0BQ36222472-022A7B49-040E-475C-B49A-927577AFC5FCQ36325265-ADAEABEA-6397-48BE-A68D-143E3C7E71E5Q36643591-FA9305BC-68D8-4EA9-8AD5-B4E0D199B0A6Q36694377-E1AB9A6D-C42B-498B-B0F4-F1E6BA06D922Q36854134-BC2151C7-372B-465B-9C8B-A2E6090AFBFDQ37310665-3273FD32-7FBD-4105-966C-E3C8B97F44BBQ37707495-41F9490A-B702-46B8-860F-FF98E74E80D9Q37785109-A07AE7EF-1D5B-47DC-B3A4-A36CAFB46083Q37905587-5D1F27AB-F6EF-4D09-B099-92060D824331Q38197628-AABA7EDA-9A5D-4553-8149-F6A69F6B9C8FQ38449441-8BBE7462-C8B6-4C35-A57E-01F7E2E62B67Q40718800-6A6E604F-4A38-4335-AFC0-93E2ED2B8B8EQ41384272-9F464F28-7D57-4989-9A99-AD7AFEF5E89DQ45904583-C35516D5-34E0-4CA0-A0CB-F9C60AD3D4F7Q48229243-AA45B2C8-C67A-48B4-AC0D-5451B49CD54AQ54863226-EE858791-09D1-4CC5-82AF-2400980E0906Q55312690-01B6A11F-1A1E-43E1-B001-C3033E709428
P2860
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
@ast
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
@en
type
label
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
@ast
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
@en
prefLabel
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
@ast
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
@en
P2093
P2860
P1476
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors
@en
P2093
A H Prowse
A R Webster
F M Richards
N A Affara
S Olschwang
P2860
P304
P407
P577
1997-04-01T00:00:00Z